Catalyst Pharmaceuticals Files 8-K

Ticker: CPRX · Form: 8-K · Filed: Aug 6, 2025 · CIK: 1369568

Catalyst Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyCatalyst Pharmaceuticals, Inc. (CPRX)
Form Type8-K
Filed DateAug 6, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-filing, 8-K

Related Tickers: CPRX

TL;DR

Catalyst Pharma filed an 8-K on Aug 6, 2025, updating corporate info.

AI Summary

Catalyst Pharmaceuticals, Inc. filed an 8-K on August 6, 2025, reporting other events and financial statements. The filing details the company's corporate information, including its incorporation in Delaware and its principal executive offices located at 355 Alhambra Circle, Suite 801, Coral Gables, Florida.

Why It Matters

This filing provides an update on Catalyst Pharmaceuticals' corporate structure and reporting, which is essential for investors to track company compliance and operational status.

Risk Assessment

Risk Level: low — This filing is a routine corporate update and does not contain information about significant financial events, acquisitions, or regulatory actions.

Key Players & Entities

  • CATALYST PHARMACEUTICALS, INC. (company) — Registrant
  • August 6, 2025 (date) — Date of Report
  • Delaware (jurisdiction) — State of incorporation
  • 355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134 (address) — Principal executive offices

FAQ

What is the primary purpose of this 8-K filing?

This 8-K filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting 'Other Events' and 'Financial Statements and Exhibits'.

When was this 8-K report filed?

The report was filed on August 6, 2025.

In which state is Catalyst Pharmaceuticals, Inc. incorporated?

Catalyst Pharmaceuticals, Inc. is incorporated in Delaware.

What is the company's principal executive office address?

The principal executive offices are located at 355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134.

What is the company's IRS Employer Identification Number?

The company's IRS Employer Identification No. is 76-0837053.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on August 6, 2025 regarding CATALYST PHARMACEUTICALS, INC. (CPRX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.